Apramycin sulfate is an orally active, acidic pH tolerant aminoglycoside antibiotic. It inhibits protein biosynthesis by targeting bacterial ribosomes and is considered a potential anti-drug-resistance antibiotic. This compound demonstrates significant efficacy against various bacterial strains, including *K. pneumoniae*, *Enterobacter*, and *E. coli*, often showing better antimicrobial activity than other common antibiotics.
- Orally active and acidic pH tolerant.
- Tolerant to aminoglycoside-modifying enzymes.
- Inhibits protein biosynthesis in bacteria.
- Potential anti-drug-resistance agent.
- Demonstrates superior antimicrobial activity against various clinical isolates.
- Shows significant efficacy in *M. tuberculosis* infection models.
- Reduces bacterial burden in *Staphylococcus aureus* septicemia models.